Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by BRYAN BURT and SHAWN GROTH.
BRYAN BURT
Connection Strength
6.924
SHAWN GROTH
  1. Minimally invasive esophagectomy: Direction of the art. J Thorac Cardiovasc Surg. 2021 Sep; 162(3):701-704.
    View in: PubMed
    Score: 0.690
  2. Commentary: Focused attention on proactive identification of deep venous thrombosis after pleurectomy/decortication for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020 10; 160(4):1075-1076.
    View in: PubMed
    Score: 0.643
  3. Percentage of tumor-infiltrating lymphocytes after chemoradiation therapy for locally advanced esophageal squamous cell carcinoma: a biomarker for pathological response rates and cancer-specific survival? Ann Transl Med. 2019 Dec; 7(Suppl 8):S310.
    View in: PubMed
    Score: 0.638
  4. Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 2019 09; 158(3):922-923.
    View in: PubMed
    Score: 0.616
  5. To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma. J Thorac Cardiovasc Surg. 2019 02; 157(2):767-768.
    View in: PubMed
    Score: 0.592
  6. A thinner peel to peel: Pleural thickness is prognostic in mesothelioma. J Thorac Cardiovasc Surg. 2019 01; 157(1):414-415.
    View in: PubMed
    Score: 0.590
  7. Subspecialty certification in thoracic oncology: Toward your next diploma. J Thorac Cardiovasc Surg. 2017 10; 154(4):1393-1394.
    View in: PubMed
    Score: 0.544
  8. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Ann Surg. 2017 08; 266(2):297-304.
    View in: PubMed
    Score: 0.543
  9. Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma. Clin Cancer Res. 2025 Jul 01; 31(13):2639-2654.
    View in: PubMed
    Score: 0.235
  10. Commentary: The enemy of good: Wishing we always have randomized data. J Thorac Cardiovasc Surg. 2022 05; 163(5):1682-1683.
    View in: PubMed
    Score: 0.173
  11. Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging. Ann Thorac Surg. 2021 11; 112(5):1568-1574.
    View in: PubMed
    Score: 0.171
  12. Utilization of Minimally Invasive Thymectomy and Margin-Negative Resection for Early-Stage Thymoma. Ann Thorac Surg. 2019 08; 108(2):405-411.
    View in: PubMed
    Score: 0.152
  13. Commentary: Adjuvant intensity-modulated radiation therapy for malignant pleural mesothelioma: Suspension of intention. J Thorac Cardiovasc Surg. 2019 09; 158(3):932-933.
    View in: PubMed
    Score: 0.152
  14. Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation?. Interact Cardiovasc Thorac Surg. 2019 03 01; 28(3):353-359.
    View in: PubMed
    Score: 0.151
  15. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019 04; 157(4):1682-1693.e1.
    View in: PubMed
    Score: 0.149
  16. Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. Ann Thorac Surg. 2017 Nov; 104(5):1679-1687.
    View in: PubMed
    Score: 0.137
  17. Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol. 2015 Aug; 16(8):e372.
    View in: PubMed
    Score: 0.118
  18. Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1318-23.
    View in: PubMed
    Score: 0.118
  19. Management of Complications After Pneumonectomy. Thorac Surg Clin. 2015 Aug; 25(3):335-48.
    View in: PubMed
    Score: 0.117
  20. Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2026 Mar 04.
    View in: PubMed
    Score: 0.062
  21. Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer. bioRxiv. 2026 Jan 02.
    View in: PubMed
    Score: 0.061
  22. Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 04; 169(4):1082-1095.e4.
    View in: PubMed
    Score: 0.056
  23. Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2023 05; 165(5):1722-1730.
    View in: PubMed
    Score: 0.049
  24. Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients. J Surg Res. 2022 11; 279:256-264.
    View in: PubMed
    Score: 0.048
  25. Demographic Landscape of Cardiothoracic Surgeons and Residents at United States Training Programs. Ann Thorac Surg. 2022 07; 114(1):108-114.
    View in: PubMed
    Score: 0.045
  26. Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma. Ann Thorac Surg. 2022 Jan; 113(1):279-285.
    View in: PubMed
    Score: 0.043
  27. Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma. J Vis Surg. 2016; 2:129.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.